Lobe Sciences Ltd. is a biopharmaceutical company, which engages in the discovery and development of transformative medicines to treat rare diseases. It involves in drug research and development using non-hallucinatory doses of stabilized psilocin-based compounds to address unmet medical needs in orphan neurological therapeutic applications. The company was founded on May 13, 2010 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Lobe Sciences Ltd market cap is $11.06M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lobe Sciences Ltd 52 week high is $0.1086 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lobe Sciences Ltd 52 week low is $0.0207 as of November 22, 2026.
Lobe Sciences Ltd stock price today is $0.0359.
Lobe Sciences Ltd stock price yesterday was $0.0363.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Lobe Sciences Ltd's P/E ratio is -2.39.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Lobe Sciences Ltd P/B ratio is 7.444.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Lobe Sciences Ltd 50-day moving average is $0.0385.